INS and hepatocellular carcinoma: In five studies using non-malignant cells (human mammary epithelial cells [45], rat H4-II-E hepatoma cells [20], and MCF-10A cells [32,41,42], insulin lispro displayed similar mitogenic potency compared to human insulin.